In keeping with its AD-counteracting effects, vitamin K2 supplementation in astroglioma C6 cells transfected with C-terminal fragment of APP was able to dose-dependently decrease cell death and ROS formation induced by Aβ peptides [137]. Here, APP is linked to Alzheimer disease.